Therapeutic Uses of Fucoidan
dc.contributor.author | Ramakrishnan, V | |
dc.contributor.author | Preetha, SP | |
dc.contributor.author | Arivuchelvan, A | |
dc.contributor.author | Parthiban, M | |
dc.contributor.author | Thangapandiyan | |
dc.contributor.author | TANUVAS | |
dc.date.accessioned | 2021-02-03T07:27:39Z | |
dc.date.available | 2021-02-03T07:27:39Z | |
dc.date.issued | 2021-01 | |
dc.description | TNV_IJCMAS_2021_10(1)2616-2630 | en_US |
dc.description.abstract | Fucoidan is a polysaccharide that primarily consists of groups of L-fucose and sulphate. As a result of its promising therapeutic results, Fucoidan is beneficial worldwide, especially in the food and pharmaceutical industries. The special biological structure is ascribed to its applaudable biological roles. Anti-oxidant, anti-tumor, anti-coagulant, antithrombotic, immunoregulatory, anti-viral, and anti-inflammatory effects are classic fucoidan-associated bioactivities. More recently, to further emphasise its therapeutic ability, a number of in vitro and in vivo experiments have been performed. This analysis reflects on the advances achieved in discovering the biological activities of fucoidan, which can be useful as a potential treatment. Therefore we have summarised the research performed in vitro and in vivo during the current decade. We expect this review and a variety of others can contribute as a theoretical basis for understanding and inspire further product development of fucoidan. | en_US |
dc.identifier.uri | https://krishikosh.egranth.ac.in/handle/1/5810160840 | |
dc.keywords | Fucoidan, Galactofucan & Therapeutic benefits | en_US |
dc.language.iso | English | en_US |
dc.pages | 2616-2630 | en_US |
dc.relation.ispartofseries | ;1 | |
dc.subject | Veterinary Science | en_US |
dc.title | Therapeutic Uses of Fucoidan | en_US |
dc.title.alternative | International Journal of Current Microbiology and Applied Sciences | en_US |
dc.type | Article | en_US |
dc.volume | 10 | en_US |
Files
Original bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- TNV_IJCMAS_2021_10(1)2616-2630.pdf
- Size:
- 222 KB
- Format:
- Adobe Portable Document Format
- Description:
- TNV_IJCMAS_2021_10(1)2616-2630
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: